Article info
PDFReview
Palivizumab for preterm infants. Is it worth it?
- Correspondence to:
Dr Embleton
Newcastle Neonatal Service, Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP, UK; n.d.embletonncl.ac.uk
Citation
Palivizumab for preterm infants. Is it worth it?
Publication history
- Accepted January 25, 2005
- First published June 21, 2005.
Online issue publication
March 22, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2005 Archives of Disease in Childhood